GlaxoSmithKline said its experimental multiple myeloma treatment showed a meaningful response in patients that have run out of three previous treatment options, in a boost for the British drugmaker's cancer drug business.
from Reuters: Health News https://ift.tt/2L8yvBQ
via
IFTTT
0 comments:
Post a Comment